·   Log in

Archive for April, 2010

Biocon’s is hiring upto 1000 staff; FY2010 net grows by 22%

Friday, April 30, 2010 21:14

Biocon, India's largest biotherapeutics firm, is planning to hire around 1000 people in the coming months.

This was posted under category: Biotech  |  Read Full Story  |  0 Comments
Tagged with: , ,

Placental stem cells safe to treat limb ischemia, says Pluristem

Friday, April 30, 2010 20:35

PLX-PAD, stem cell therapy for the treatment of critical limb ischemia (CLI) and end-stage of peripheral artery disease (PAD) by Pluristem Therapeutics, has been found safe in human trials.

This was posted under category: Biotech  |  Read Full Story  |  0 Comments
Tagged with: ,

Shantha Biotech recalls children’s vaccine Shan 5 from global markets after safety concerns: Report

Friday, April 30, 2010 20:31

Sanofi Aventis-owned Shantha Biotech is recalling five-in-one vaccines Shan5 from across global markets following safety concerns.

This was posted under category: Biotech, Featured  |  Read Full Story  |  0 Comments

Lucentis (ranibizumab) could treat diabetic blindness, says new study

Friday, April 30, 2010 20:30

Lucentis (ranibizumab) may come as new treatment for vision loss due to diabetes, according to the findings from a new study.

This was posted under category: Biotech  |  Read Full Story  |  0 Comments
Tagged with: ,

Cadila Healthcare reports 67% peak in FY2010 net profits; offers 100% dividend

Thursday, April 29, 2010 20:56

India's Cadila Healthcare has reported a 67% jump in consolidated net profit hasĀ  to Rs 505.14 crore from Rs 303.08 crore in the previous year during the year ended March 2010 on account of growth in formulation and APIs exports.

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with:

Gonorrhea could go incurable as bacteria turn resistant to antibiotics: WHO

Thursday, April 29, 2010 20:32

The sexually transmitted diseases gonorrhea could soon become a threat as most of the widely used antibiotics to treat the bacterial infection are increasingly getting ineffective due to resistance.

This was posted under category: health  |  Read Full Story  |  0 Comments
Tagged with: ,

Cervical cancer vaccine Gardasil tested in children before studying in adults: Indian health ministry official

Thursday, April 29, 2010 20:16

Cervical cancer vaccine Gardasil study, which has allegedly led to the death of 6 girls in Indian village of Khammam, was conducted in children before evaluating its safety in adult girls, senior officials with Indian government has stated.

This was posted under category: Featured, health  |  Read Full Story  |  0 Comments
Tagged with: ,

Prasugrel to prevent blood clots in heart vessels launched in India by Glenmark

Thursday, April 29, 2010 20:11

Anti-blood clotting drug prasugrel (Effient) has been launched in India by Glenmark.

This was posted under category: Industry  |  Read Full Story  |  1 Comment

AstraZeneca illegally promoted quetiapine (Seroquel) to treat aggression, anger; pays $510m fine in US to

Thursday, April 29, 2010 12:27

Anglo-Swedish pharmaceutical firm AstraZeneca has been made to pay a $510 million for illegally promoting its quetiapine (Seroquel) for diseases the anti-psychotic drug has not been approved in US.

This was posted under category: Legal  |  Read Full Story  |  0 Comments

Suven’s 5-HT compounds to treat Alzheimer’s, schizophrenia get more patents from New Zealand and India

Wednesday, April 28, 2010 18:54

Suven Life's investigative 5-HT compounds with a potential to treat neurodegenerative disorders won patents from New Zealand and India.

This was posted under category: Patents  |  Read Full Story  |  0 Comments
Tagged with: